Having Belly Fat Can Increase Your Risk
Researchers at the Radiological Society of North America have linked a specific type of body fat to the development of ...
Day: November 20, 2023
IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA
SAN DIEGO — Monthly use of intravenously administered secukinumab (Cosentyx) proved its efficacy over placebo in treating psoriatic arthritis (PsA) and ...
How Will Germany Respond to the Global Nursing Shortage?
BERLIN — The shortage of nurses around the world is extremely challenging in many ways for healthcare systems. Nurses at ...
New Guidelines for Severe PMS, PMDD Advise Antidepressants, CBT and Birth Control
ACOG has released a new set of guidelines for the treatment of PMS and PMDD (Premenstrual dysphoric disorder).Treatments that are ...
‘Silent Atherosclerosis’ Can Be Especially Dangerous for Young People
A new study finds risk factors like high cholesterol and high blood pressure should be addressed earlier in life to ...
Already-Available Drug Could Help Treat Type 1 Diabetes
The drug α-difluoromethylornithine (DFMO) may help preserve beta-cell function in people with new-onset type 1 diabetes, new preliminary data suggest. ...
Novel Blood Test Can Detect Rheumatoid Arthritis
SAN DIEGO – Researchers say they've developed a novel blood-based assay that can differentiate patients with seropositive or seronegative rheumatoid arthritis ...
Single Injection Reduces Blood Pressure for 6 Months
A single injection of the investigational antihypertensive agent zilebesiran (Alnylam Pharmaceuticals) effectively lowered blood pressure in adults with mild to ...
Asundexian Phase 3 AF Study Halted for Lack of Efficacy
The phase 3 OCEANIC-AF trial of the investigational oral factor XI inhibitor asundexian (Bayer) has been stopped early owing to ...
FDA OKs Symplicity Renal Denervation System for Hypertension
The US Food and Drug Administration (FDA) has approved Medtronic's Symplicity Spyral renal denervation system for the treatment of hypertension, ...
Bayer Recalls One Lot of Cancer Drug Vitrakvi
(Reuters) -Bayer said on Friday it was voluntarily recalling one lot of its cancer drug Vitrakvi in the U.S. due ...
Gender-Affirming Care for Kids Dropped In Some States Where It’s Legal
Share on PinterestAccess to gender-affirming care is crucial to the well-being of transgender and gender-diverse young people. Maskot/Getty ImagesA growing ...
FDA Identifies Recall of Medical Pump System as Most Serious
(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday said it had identified the recall of B. Braun ...
What’s Behind the Scramble for Semaglutide?
Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in ...
Covid inquiry: ‘Lack of leadership’ as virus spread in autumn 2020
Sir Patrick criticises Boris Johnson for being weak and indecisive in autumn 2020, in diary entries. Source link : https://www.bbc.co.uk/news/health-67479548?at_medium=RSS&at;_campaign=KARANGA ...
FDA Panel Flags Insufficient Data for Chronic Cough Drug
(Reuters) - Advisers to the U.S. health regulator said on Friday that data on Merck's chronic cough drug does not ...
Surgery Is Falling Out of Favor in Rectal Cancer
TOPLINE: Proctectomy and other surgeries are falling out of favor to treat stage II and III rectal cancer in the ...
Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL
Prophylaxis with apixaban (Eliquis) failed to reduce the rate of venous thromboembolism (VTE) in children with newly diagnosed acute lymphoblastic ...
Proteins Predict Signs of Alzheimer’s Disease
Protein indicators of subclinical peripheral heath in plasma were linked with markers of Alzheimer's disease and neurodegeneration, cross-sectional proteomic analyses ...
Cannabis addiction may be partly down to genetics
Cannabis use disorder may be influenced by geneticsguruXOX/Shutterstock People who develop a cannabis use disorder share certain genetic markers, and ...
NEWSHEALTH : Cannabis addiction may be partly down to genetics